Ideaya Biosciences Inc [IDYA] stock is trading at $35.41, down -0.25%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IDYA shares have gain 4.73% over the last week, with a monthly amount glided 4.18%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Guggenheim started tracking the stock with Buy rating on September 18, 2025, and set its price target to $50. On September 04, 2025, Citizens JMP initiated with a Mkt Outperform rating and assigned a price target of $41 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $40 on September 04, 2025. TD Cowen initiated its recommendation with a Buy. In a note dated June 26, 2025, Wells Fargo initiated an Overweight rating and provided a target price of $44 on this stock.
Ideaya Biosciences Inc [IDYA] stock has fluctuated between $13.45 and $37.08 over the past year. Currently, Wall Street analysts expect the stock to reach $42.43 within the next 12 months. Ideaya Biosciences Inc [NASDAQ: IDYA] shares were valued at $35.41 at the most recent close of the market. An investor can expect a potential return of 19.82% based on the average IDYA price forecast.
Analyzing the IDYA fundamentals
Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -54.89%, Pretax Profit Margin comes in at -47.29%, and Net Profit Margin reading is -47.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.31 and Total Capital is -0.39. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.03 points at the first support level, and at 34.64 for the second support level. However, for the 1st resistance point, the stock is sitting at 35.90, and for the 2nd resistance point, it is at 36.38.
Ratios To Look Out For
For context, Ideaya Biosciences Inc’s Current Ratio is 12.44. In addition, the Quick Ratio stands at 12.44 and the Cash Ratio stands at 2.07. Considering the valuation of this stock, the price to sales ratio is 14.45, the price to book ratio is 2.84.
